Related Experiment Videos
[Nodular regenerative hyperplasia associated with primary antiphospholipid syndrome]
J F Cadranel1, R Demontis, C Guettier
1Unité d'Hépatologie, Centre hospitalier Laennec, Creil.
Gastroenterologie Clinique Et Biologique
|January 1, 1996
Summary
Nodular regenerative hyperplasia of the liver, a condition without fibrotic septa, may stem from blood vessel obstruction. This case links primary antiphospholipid syndrome to liver nodularity, suggesting a thrombotic role in its development.
Area of Science:
- Hepatology
- Immunology
- Vascular Medicine
Background:
- Nodular regenerative hyperplasia (NRH) is characterized by diffuse hepatic nodularity without fibrosis.
- It is often associated with conditions affecting portal tract vasculature, including venous or arterial obstruction.
- Primary antiphospholipid syndrome (APS) is an autoimmune disorder associated with a hypercoagulable state.
Observation:
- A 45-year-old woman with primary APS presented with ischemic stroke and acute arterial ischemia of the left leg.
- She exhibited high titers of serum anticardiolipin antibodies.
- Liver biopsy confirmed nodular regenerative hyperplasia, accompanied by anicteric cholestasis.
Findings:
- The case demonstrates a correlation between primary antiphospholipid syndrome and nodular regenerative hyperplasia of the liver.
- Histological confirmation of NRH in the context of APS and thrombotic events was established.
- Anicteric cholestasis was observed as a clinical manifestation associated with NRH in this patient.
Implications:
- This case adds to the evidence suggesting that thrombotic events may contribute to the pathogenesis of nodular regenerative hyperplasia.
- Understanding the link between APS and NRH could improve diagnostic and therapeutic strategies for patients with both conditions.
- Further research into the vascular mechanisms underlying NRH in hypercoagulable states is warranted.